139 results on '"Schwaibold, Hartwig"'
Search Results
2. Renaissance der Regionalkongresse
3. Nichtinvasives Harnblasenkarzinom
4. Radiotherapy for Prostate Cancer: is it ‘what you do’ or ‘the way that you do it’? A UK Perspective on Technique and Quality Assurance
5. Priapism
6. Pelvic Lymphadenectomy in the Management of Prostate Cancer
7. Modular Training in Endoscopic Extraperitoneal Radical Prostatectomy
8. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives
9. Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received
10. Long-Term Intravesical Adjuvant Chemotherapy Further Reduces Recurrence Rate Compared with Short-Term Intravesical Chemotherapy and Short-Term Therapy with Bacillus Calmette-Guérin (BCG) in Patients with Non–Muscle-Invasive Bladder Carcinoma
11. An Overview of the Diagnosis and Treatment of Erectile Dysfunction
12. Categorisation of complications of endoscopic extraperitoneal and laparoscopic transperitoneal radical prostatectomy
13. MR cystography for bladder tumor detection
14. LAPAROSCOPIC RADICAL PROSTATECTOMY IN THE UK: DEFINING AND OVERCOMING THE OBSTACLES
15. Toxicity of local, continuous and cyclic, high-dose bladder perfusion with recombinant and natural interleukin-2 in advanced cancer of the urinary bladder
16. The value of a second transurethral resection for T1 bladder cancer
17. Modular surgical training for endoscopic extraperitoneal radical prostatectomy
18. Is intravesical chemotherapy for superficial bladder cancer still justified?
19. The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer
20. Earliest Time to Onset of Action Leading to Successful Intercourse with Vardenafil Determined in an At‐Home Setting: A Randomized, Double‐Blind, Placebo‐Controlled Trial
21. Second look URS oder low dose CT - was ist die geeignete Nachsorge nach einer tubeless Mini-PNL?
22. Inhalation of Natural Interleukin-2: Effectivity and Toxicity in Patients with Pulmonary Metastases of Renal Cell Carcinoma
23. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life
24. DETECTION OF LOSS OF HETEROZYGOSITY IN THE P53 TUMOR-SUPPRESSOR GENE WITH PCR IN THE URINE OF PATIENTS WITH BLADDER CANCER
25. Nichtinvasives Harnblasenkarzinom
26. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future perspectives
27. Radiotherapy for Prostate Cancer: is it ‘what you do’ or ‘the way that you do it’? A UK Perspective on Technique and Quality Assurance
28. Laparoscopically resected ureteric pseudotumour in a female patient
29. ORAL INTAKE OF POPPY SEED: A RELIABLE AND SIMPLE METHOD FOR DIAGNOSING VESICO-ENTERIC FISTULA
30. Modular Training in Endoscopic Extraperitoneal Radical Prostatectomy
31. Pelvic Lymphadenectomy in the Management of Prostate Cancer
32. Beleuchtung bestehender Indikationen
33. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future pers
34. 1265 NUCLEAR MATRIX PROTEIN 22 (NMP22) AS URINE-BASED TUMOR MARKER FOR DETECTION OF PRIMARY AND RECURRENT BLADDER CANCER: COMPARISON OF THE POINT-OF-CARE VERSION (BLADDERCHEK®) AND THE ELISA
35. Onkologische, metabolische und funktionelle Aspekte
36. 836: Long Term Prophylaxis with Mitomycin C (MMC) Significantly Reduces Tumor Recurrence Compared to Short Term Prophylaxis with MMC or Bacillus Calmette-Guerin (BCG) In Non Muscle-Invasive Bladder Cancer (NMIBC)
37. The Year in Urology
38. The evidence for urology
39. 271: Long Term Prophylaxis with Mitomycin C (MMC) Further Reduces Tumor Recurrence Compared to Short Term Prophylaxis with MMC or Bacillus Calmette-Guerin (BCG)
40. 290: Reduction of Early Tumor Recurrences in pTa/pT1 Bladder Carcinoma Using an Extended Resection Protocol
41. Modular Training in Endoscopic Extraperitoneal Radical Prostatectomy.
42. Pelvic Lymphadenectomy in the Management of Prostate Cancer.
43. Reliability of MR Imaging—Based Virtual Cystoscopy in the Diagnosis of Cancer of the Urinary Bladder
44. Reduction of early tumour recurrences in superficial bladder carcinoma using an extended resection protocol
45. Relevance of p53 Gene Alterations for Tumor Recurrence in Patients with Superficial Transitional Cell Carcinoma of the Bladder
46. Erythropoetin in Urologic Oncology
47. The Year in Urology
48. Screening for p53 Mutations in Superficial Transitional Cell Carcinoma of the Bladder with an Improved Technique Consisting of Microdissection, Polymerase Chain Reaction, Temperature Gradient Gel Electrophoresis, and Direct Sequencing
49. IMPROVEMENT OF URETEROILEAL ANASTOMOSIS IN CONTINENT URINARY DIVERSION WITH MODIFIED LE DUC PROCEDURE
50. p53 in noncancerous bladder mucosa as a marker of disease recurrence in patients with superficial transitional cell carcinoma of the bladder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.